Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: Absence of development of age-related obesity

American Journal of Physiology - Endocrinology and Metabolism

Volumn 287, Issue 1 50-1, 2004, Pages

  Di Gregorio, Gina B ^a   Hensley, Lori ^a   Lu, Tong ^a   Ranganathan, Gouri ^a   Kern, Philip A ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Adipose tissue; Interleukin 6

Indexed keywords

CARBOHYDRATE; GLUCOSE; HEPARIN; INSULIN; INTERLEUKIN 6; LEPTIN; LIPID; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME ACTIVITY; GENE MUTATION; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIPID METABOLISM; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; AGING; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CARBOHYDRATE METABOLISM; DIET; DIETARY FATS; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; LIPID METABOLISM; MICE; MICE, INBRED C57BL; MUTAGENESIS, SITE-DIRECTED; OBESITY;

EID: 3042739678     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00189.2003     Document Type: Article

References (32)

1. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann T, Shulman GI, and Kahn BB. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409: 729-733, 2001.
2. Armario A, Hernandez J, Bluethmann H, and Hidalgo J. IL-6 deficiency leads to increased emotionality in mice: evidence in transgenic mice carrying a null mutation for IL-6. J Neuroimmunol 92: 160-169, 1998.
3. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, Vidal H, and Hainque B. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85: 3338-3342, 2000.
4. Berg M, Fraker DL, and Alexander HR. Characterization of differentiation factor/leukaemia inhibitory factor effect on lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes. Cytokine 6: 425-432, 1994.
5. Chua S Jr, Liu SM, Li Q, Yang L, Thassanapaff VT, and Fisher P. Differential beta cell responses to hyperglycaemia and insulin resistance in two novel congenic strains of diabetes (FVB-Lepr (db)) and obese (DBA-Lep (ob)) mice. Diabetologia 45: 976-990, 2002.
6. Colombo C, Haluzik M, Cutson JJ, Dietz KR, Marcus-Samuels B, Vinson C, Gavrilova O, and Reitman ML. Opposite effects of background genotype on muscle and liver insulin sensitivity of lipoatrophic mice. Role of triglyceride clearance. J Biol Chem 278: 3992-3999, 2003.
7. DeFronzo RA, Bonadonna RC, and Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15: 318-368, 1992.
8. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, and Felber JP. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30: 1000-1007, 1981.
9. Fernandez-Real JM, Broch M, Vendrell J, Gutierrez C, Casamitjana R, Pugeat M, Richart C, and Ricart W. Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes 49: 517-520, 2000.
10. Fried SK, Bunkin DA, and Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83: 847-850, 1998.
11. Greenberg AS, Nordan RP, McIntosh J, Calvo JC, Scow RO, and Jablons D. Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res 52: 4113-4116, 1992.
12. Hotamisligil GS, Shargill NS, and Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259: 87-91, 1993.
13. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, and Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599, 2000.
14. Kahn BB and Flier JS. Obesity and insulin resistance. J Clin Invest 106: 473-481, 2000.
15. Kern PA, Di Gregorio GB, Lu T, Rassouli N, and Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes 52: 1779-1785, 2003.
16. Kern PA, Ranganathan S, Li C, Wood L, and Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity-associated insulin resistance. Am J Physiol Endocrinol Metab 280: E745-E751, 2001.
17. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, and Köhler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368: 339-342, 1994.
18. Kubaszek A, Pihlajamaki J, Komarovski V, Lindi V, Lindstrom J, Eriksson J, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, and Laakso M. Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 52: 1872-1876, 2003.
19. Leiter EH, Coleman DL, Eisenstein AB, and Strack I. A new mutation (db3J) at the diabetes locus in strain 129/J mice. 1. Physiological and histological characterization. Diabetologia 19: 58-65, 1980.
20. Martinez-Botas J, Anderson JB, Tessier D, Lapillonne A, Chang BH, Quast MJ, Gorenstein D, Chen KH, and Chan L. Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat Genet 26: 474-479, 2000.
21. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, and Kahn BB. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415: 339-343, 2002.
22. Nilsson-Ehle P and Schotz MC. A stable radioactive substrate emulsion for assay of lipoprotein lipase. J Lipid Res 17: 536-541, 1976.
23. Ong JM, Simsolo RB, Saghizadeh M, Goers JWF, and Kern PA. Effects of exercise training and feeding on lipoprotein lipase gene expression in adipose tissue, heart, and skeletal muscle of the rat. Metabolism 44: 1596-1605, 1995.
24. Orban Z, Remaley AT, Sampson M, Trajanoski Z, and Chrousos GP. The differential effect of food intake and beta-adrenergic stimulation on adipose-derived hormones and cytokines in man. J Clin Endocrinol Metab 84: 2126-2133, 1999.
25. Samoilova EB, Horton JL, Hilliard B, Liu TS, and Chen Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J Immunol 161: 6480-6486, 1998.
26. Steppan CM and Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 13: 18-23, 2002.
27. Sundgren-Andersson AK, Ostlund P, and Bartfai T. IL-6 is essential in TNF-α-induced fever. Am J Physiol Regul Integr Comp Physiol 275: R2028-R2034, 1998.
28. Tsigos C, Papanicolaou DA, Kyrou I, Defensor R, Mitsiadis CS, and Chrousos GP. Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 82: 4167-4170, 1997.
29. Unger RH. Lipotoxic diseases. Annu Rev Med 53: 319-336, 2002.
30. Uysal KT, Wiesbrock SM, Marino MW, and Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389: 610-614, 1997.
31. Wallenius K, Wallenius V, Sunter D, Dickson SL, and Jansson JO. Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochem Biophys Res Commun 293: 560-565, 2002.
32. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, and Jansson JO. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8: 75-79, 2002.